课题基金 / 基金详情

Functions of Notch Signaling in Marginal Zone B Cell Differentiation and Homeostasis

Functions of Notch Signaling in Marginal Zone B Cell Differentiation and Homeostasis
Notch 信号在边缘区 B 细胞分化和稳态中的功能
批准号:
418370-2012
负责人:
Guidos, Cynthia
金额:
$3.86万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-01-01 至 2014-12-31

项目摘要

项目成果

Guidos, Cynthia的其他基金

相似基金

相关文献

中文摘要
翻译
我研究计划的长期目标是阐明控制细胞谱系承诺和分化的分子机制。我们使用小鼠免疫系统作为我们的实验模型,因为几十年的研究已经提供了广泛的细胞,分子和遗传事件的特征,这些事件调节淋巴细胞的发育和功能,免疫的主要效应器。有两种主要的淋巴细胞系,T细胞和B细胞,分别介导细胞和体液免疫反应。有趣的是,在淋巴细胞发育过程中会产生两种不同功能的T细胞和B细胞。“传统”淋巴细胞表达针对罕见微生物抗原的克隆多样抗原受体,这些抗原受体在数周内触发它们分化为免疫效应细胞或记忆细胞。相比之下,先天样淋巴细胞对常见微生物成分的特异性抗原受体较少,抗原暴露会促使它们在数小时内分化为抗微生物效应细胞,而不是数天。因此,先天样淋巴细胞是“天然的”效应/记忆细胞,在常规淋巴细胞介导适应性免疫应答之前提供早期免疫保护。本研究的重点是先天样边缘区(MZ) B细胞,它表达对常见细菌壁部分的特异性受体,并能迅速分化为抗体分泌细胞。有趣的是,MZ B细胞的产生和维持,而不是传统的B细胞,需要激活Notch2受体。然而,Notch2信号在这些过程中的具体功能尚不清楚。因此,我们的目标是确定Notch2激活促进先天样MZ B细胞分化和稳态的机制。
英文摘要
The long-term goal of my research program is to elucidate molecular mechanisms that govern cellular lineage commitment and differentiation. We use the murine immune system as our experimental model, since decades of study have provided extensive characterization of cellular, molecular and genetic events that regulate the development and function of lymphocytes, the major effectors of immunity. There are two major lymphocyte lineages, T and B cells, which mediate cellular versus humoral immune responses, respectively. Interestingly, two different functional classes of both T and B cells are produced during lymphocyte development. 'Conventional' lymphocytes express clonally diverse antigen receptors specific for rare microbial antigens, which trigger their differentiation into immune effector or memory cells over the course of several weeks. In contrast, innate-like lymphocytes have less diverse antigen receptor repertoires specific for common microbial components, and antigen exposure drives their differentiation into anti-microbial effector cells within hours rather than days. Thus, innate-like lymphocytes are "natural" effector/memory cells that provide early immune protection well before conventional lymphocytes can mediate adaptive immune responses. This proposal is focused on innate-like marginal zone (MZ) B cells, which express receptors specific for common bacterial wall moieties, and can rapidly differentiate into antibody-secreting cells. Interestingly, generation and maintenance of MZ B cells, but not conventional B cells, requires activation of the Notch2 receptor. However, the specific functions of Notch2 signaling in these processes are unknown. Therefore, our objective is to define mechanisms by which Notch2 activation promotes differentiation and homeostasis of innate-like MZ B cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functions of Notch Signaling in Marginal Zone B Cell Differentiation and Homeostasis
  • 批准号:
    418370-2012
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.86万
  • 财政年份:
    2016
  • 负责人:
    Guidos, Cynthia
  • 依托单位:
Functions of Notch Signaling in Marginal Zone B Cell Differentiation and Homeostasis
  • 批准号:
    418370-2012
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.86万
  • 财政年份:
    2015
  • 负责人:
    Guidos, Cynthia
  • 依托单位:
Functions of Notch Signaling in Marginal Zone B Cell Differentiation and Homeostasis
  • 批准号:
    418370-2012
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.86万
  • 财政年份:
    2014
  • 负责人:
    Guidos, Cynthia
  • 依托单位:
Functions of Notch Signaling in Marginal Zone B Cell Differentiation and Homeostasis
  • 批准号:
    418370-2012
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.86万
  • 财政年份:
    2012
  • 负责人:
    Guidos, Cynthia
  • 依托单位:
国内基金
海外基金
基于 ANKRD22 介导的脂代谢重编程激活Notch4/HES1 通路促进巨噬细胞获得免疫抑制表型机制研究
  • 批准号:
    ZCLMS26H1601
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    肖于飞
  • 依托单位:
电针调控 Notch 信号通路促进脑缺血再灌注损伤神经血管单元调节和保护作用
  • 批准号:
    2026JJ82306
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    袁高明
  • 依托单位:
MPE细胞团中α-SMA+肿瘤细胞激活Notch 通路促恶性进展的作用机制研究
  • 批准号:
    JCZRQNB202600536
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: